Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000028

Chief Scientific Officer acquired 6,775,068 shares (other)

From the SEC's structured data for this filing

Trades in this filing

NIGALAYE ASHOK G · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2013-03-25 Other acquisition : show line 1 in the form +6,775,068 $0.04 $250,000 15,060,666 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2013-03-25 Other acquisition : show line 2 in the form Warrants +6,666,667 2,436,665 I
Loading xslF345X03/primary_doc.xml…